Aurinia Pharmaceuticals (AUPH) Inventory (2020 - 2026)

Aurinia Pharmaceuticals has reported Inventory for 7 years, with the latest figure at $46.4 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory changed 0.47% year-over-year to $46.4 million; the trailing twelve-month figure through Mar 2026 stood at $46.4 million (changed 0.47% YoY), and the FY2025 full-year result was $45.7 million, up 16.47% from the prior year.
• Inventory for Q1 2026 stood at $46.4 million, up from $45.7 million in the prior quarter.
• The five-year high for Inventory was $46.5 million in Q2 2025, with the low at $24.8 million in Q4 2022.
• Historically, Inventory has averaged $36.8 million across 5 years, with a median of $38.9 million in 2024.
• Annual changes were most pronounced in 2022 — Inventory surged 64.82% — and 2024, when it decreased 1.2%.
• Aurinia Pharmaceuticals' Inventory stood at $24.8 million in 2022, then soared by 60.41% to $39.7 million in 2023, then slipped by 1.2% to $39.2 million in 2024, then increased by 16.47% to $45.7 million in 2025, then grew by 1.58% to $46.4 million in 2026.
• The last three Inventory figures came in at $46.4 million (Q1 2026), $45.7 million (Q4 2025), and $44.8 million (Q3 2025), per Business Quant data.